There are guardrails and trial structure built into a clinical trial like this to minimize bias. The drug maker, Novo Nordisk, will share their findings and data publicly
The first oral GLP-1RA, semaglutide (oral formulation), was approved in 2019 for the treatment of type 2 diabetes, and is considered a breakthrough in the field of oral peptide delivery 3
Semaglutide is most effective when used as part of a comprehensive treatment plan that includes a healthy diet and regular exercise, and not as a stand-alone quick fix
Flat-rate: the price stays the same regardless of dose
Only very small molecules can reliably pass through the skin, which is why patches work for things like nicotine, certain hormones (like estrogen), or some pain medications
The under-eye and orbital reader All ages tear trough and crow's feet The under-eye area is thin (around 0.5mm of total skin thickness in some patients) and highly visible